» Articles » PMID: 16769013

Fetal Growth Risk Curves: Defining Levels of Fetal Growth Restriction by Neonatal Death Risk

Overview
Publisher Elsevier
Date 2006 Jun 14
PMID 16769013
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We developed a fetal growth risk curve that delineates the birth weight values for gestational age that reflect a 2-, 2.5-, and 3-fold neonatal death risk relative to infants with normal fetal growth.

Study Design: We analyzed 18,085,052 single gestation infants (25-42 weeks) who were born to US resident mothers from 1996 to 2000. Multivariate models were used to predict the relationship between neonatal death and birth weight percentile. Fetal risk curves were derived on the basis of birth weight percentile-specific neonatal mortality rates that were relative to an average rate of neonatal death for a comparison group that was representative of typical growth (ie, infants between 45th-55th birth weight percentiles for gestational age).

Results: The 10th percentile of birth weight for gestational age is associated with an increased but variable risk of neonatal death relative to the comparison group across the spectrum of gestational ages. At 26 weeks of gestation, infants at the 10th percentile experienced a 3-fold risk of dying within the first 28 days of life (relative to the comparison group); whereas at 40 weeks, the risk was 1.13.

Conclusion: Fetal growth risk curves facilitate the identification of populations of infants whose risk of death are deemed excessive compared with that of infants at the norm of fetal growth and may be useful for counseling pregnant women.

Citing Articles

A new birth weight chart and optimal birth weight percentiles for predicting infant mortality.

Chang J, Chen Y, Chen I, Lin W, Lin C, Lin Y Sci Rep. 2024; 14(1):30123.

PMID: 39627233 PMC: 11615366. DOI: 10.1038/s41598-024-78834-0.


Intravoxel incoherent motion MRI to assess feto-placental diffusion and perfusion properties in small fetuses.

Ercolani G, Capuani S, Celli V, Ciulla S, Ninkova R, Gennarini M Radiol Med. 2024; 130(1):81-95.

PMID: 39541066 DOI: 10.1007/s11547-024-01918-4.


Outcomes of induction vs prelabor cesarean delivery at <33 weeks for hypertensive disorders of pregnancy.

Bushman E, Grobman W, Bailit J, Reddy U, Wapner R, Varner M Am J Obstet Gynecol MFM. 2023; 5(8):101032.

PMID: 37244639 PMC: 10521213. DOI: 10.1016/j.ajogmf.2023.101032.


PERINATAL OUTCOMES OF PREGNANT WOMEN WITH TYPE 1 DIABETES MELLITUS: COMPARISON OF MULTIDOSE INJECTION AND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION.

Beksac M, Fadiloglu E, Tanacan A Acta Endocrinol (Buchar). 2020; 16(1):53-58.

PMID: 32685039 PMC: 7364006. DOI: 10.4183/aeb.2020.53.


An outcome-based definition of low birthweight for births in low- and middle-income countries: a secondary analysis of the WHO global survey on maternal and perinatal health.

Laopaiboon M, Lumbiganon P, Rattanakanokchai S, Chaiwong W, Souza J, Vogel J BMC Pediatr. 2019; 19(1):166.

PMID: 31132994 PMC: 6535858. DOI: 10.1186/s12887-019-1546-z.